4.3 Article

Predictors for future development of systemic lupus erythematosus in Korean Sjogren's syndrome patients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Rheumatology

Patients with early-onset primary Sjogren's syndrome have distinctive clinical manifestations and circulating lymphocyte profiles

Lin Wei et al.

Summary: Patients with early-onset primary Sjogren's syndrome have distinct clinical manifestations and greater activation of the cellular immune system, leading to more severe clinical symptoms and immunological features, and an unfavorable prognosis.

RHEUMATOLOGY (2022)

Article Rheumatology

Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients

Massimo Radin et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2022)

Article Rheumatology

Hypocomplementemia in primary Sjogren's syndrome: association with serological, clinical features, and outcome

Wei Lin et al.

Summary: This study assessed the clinical characteristics of HC in pSS and explored the associated risk factors and prognosis. The study found that HC is not uncommon in pSS and is independently associated with main clinical and immunological features. Patients with pSS-HC are more likely to develop SLE and require more aggressive treatment.

CLINICAL RHEUMATOLOGY (2022)

Review Immunology

Predicting progression from undifferentiated connective tissue disease to definite connective tissue disease: A systematic review and meta-analysis

Sarah Dyball et al.

Summary: This article conducted a systematic review and meta-analysis to identify clinical and laboratory features and biomarkers that can predict the progression of undifferentiated connective tissue disease (UCTD). The results showed that younger age, serositis, and the presence of anti-dsDNA antibodies were the most important predictors for the progression to systemic lupus erythematosus (SLE), while puffy fingers, abnormal nailfold changes, and anti-topoisomerase-I were the main indicators for the progression to systemic sclerosis (SSc). In addition, HLA molecules, regulatory T cell shift, pro-inflammatory cytokines, and complement activation products were identified as potential predictors for the evolution of the disease.

AUTOIMMUNITY REVIEWS (2022)

Article Rheumatology

Prognostic factors for the development of systemic lupus erythematosus in patients with immune thrombocytopenia

Soo Min Ahn et al.

Summary: This study aimed to investigate the clinical characteristics and risk factors for the development of systemic lupus erythematosus (SLE) in patients with primary immune thrombocytopenia (ITP). The results showed that young age, organ bleeding, and positive antinuclear antibody (ANA) were significantly associated with the development of SLE. Close follow-up is recommended for patients with primary ITP, especially those with the mentioned risk factors.

ARTHRITIS RESEARCH & THERAPY (2022)

Review Rheumatology

Sjogren's syndrome and systemic lupus erythematosus: links and risks

Sandra Gofinet Pasoto et al.

OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS (2019)

Review Immunology

Clinical and immunological parameters of Sjogren's syndrome

Konstantia Psianou et al.

AUTOIMMUNITY REVIEWS (2018)

Review Rheumatology

Genetics of systemic lupus erythematosus and Sjogren's syndrome: an update

Maria Teruel et al.

CURRENT OPINION IN RHEUMATOLOGY (2016)

Article Rheumatology

Polyautoimmunity in Sjogren Syndrome

Juan-Manuel Anaya et al.

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2016)

Article Rheumatology

Genetics in Sjogren Syndrome

Tove Ragna Reksten et al.

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2016)

Article Multidisciplinary Sciences

Predicting the Outcome of Sjogren's Syndrome-Associated Non-Hodgkin's Lymphoma Patients

Aristea Papageorgiou et al.

PLOS ONE (2015)

Article Rheumatology

Validation of EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)

Raphaele Seror et al.

ANNALS OF THE RHEUMATIC DISEASES (2015)

Article Biochemistry & Molecular Biology

The complement system in B cell regulation

MC Carroll

MOLECULAR IMMUNOLOGY (2004)